Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Neuropsychopharmacology

• Publication date

  1991-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0924-977X(91)90007-HPMID 1688013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and effects on prolactin of remoxipride in patients with tardive dyskinesia

  2005cited by this paper
• Changes in serum prolactin after electroconvulsive and epileptic seizures

  2004cited by this paper
• High dosage haloperidol therapy in chronic schizophrenic patients: A double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin

  2004cited by this paper
• Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

  1991cited by this paper
• Selective dopamine D2 antagonist, remoxipride,in the treatment of acute schizophrenia - results of proclactin studies

  1990cited by this paper
• Perfenazin decanoat og flupentixol decanoat i langtidsbehandling Serumniveau ved laveste effektive dosis

  1990cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• Remoxipride and haloperidol in schizophrenia: a double‐blind multicentre study.

  1990cited by this paper
• Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms

  1990cited by this paper
• Pharmacokinetics and antipsychotic effect of remoxipride in chronic schizophrenic patients

  1990cited by this paper
• Clinical profile of remoxipride ‐ a combined analysis of a comparative double‐blind multicentre trial programme

  1990cited by this paper
• A double‐blind comparative trial of remoxipride and haloperidol in the treatment of schizophrenia

  1990cited by this paper
• Determination of remoxipride in plasma and urine by reversed-phase column liquid chromatography.

  1990cited by this paper
• Clinical evaluation of alprazolam in patients with panic disorder: A double‐blind comparison with imipramine

  1990cited by this paper
• Studies on the mechanism(s) for the ‘atypical’ neuroleptic activity of remoxipride

  1990cited by this paper
• Biochemical pharmacology of the atypical neuroleptic remoxipride

  1990cited by this paper
• Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.

  1989cited by this paper
• The relationship between perphenazine plasma levels and clinical response in acute schizophrenia.

  1989cited by this paper
• Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patients

  1988cited by this paper
• Novel antipsychotic drugs share high affinity for sigma receptors.

  1988cited by this paper
• Novel antipsychotic drugs share high affinity for σ receptors

  1988cited by this paper
• Reversed-phase ion-pair liquid chromatographic method for the determination of low concentrations of haloperidol in plasma.

  1988cited by this paper
• A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia

  1988cited by this paper
• Prolactin and neuroleptic drugs.

  1988cited by this paper
• Plasma Concentrations of Haloperidol and Prolactin and Clinical Outcome in Acutely Psychotic Patients

  1988cited by this paper
• Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

  1988cited by this paper
• Plasma fluphenazine concentrations in outpatients receiving fluphenazine decanoate (Modecate)

  1986cited by this paper
• Serum and cerebrospinal fluid levels of fluphenazine–relationship to treatment response in schizophrenic patients

  1986cited by this paper
• Plasma haloperidol levels and clinical response: confounding variables.

  1985cited by this paper
• Monitorización de los niveles plasmáticos de haloperidol en la esquizofrenia: utilidad clínica

  1985cited by this paper
• Serum and Cerebrospinal Fluid Prolactin Patterns during Neuroleptic Treatment in Schizophrenic Patients

  1985cited by this paper
• Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study.

  1985cited by this paper
• Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.

  1984cited by this paper
• The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol.

  1984cited by this paper
• Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis.

  1984cited by this paper
• Neuroleptic concentrations and clinical response.

  1984cited by this paper
• Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients.

  1982cited by this paper
• Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients.

  1982cited by this paper
• Low serum neuroleptic levels predict relapse in schizophrenic patients.

  1982cited by this paper
• The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations.

  1980cited by this paper
• Prolactin and neuroleptics: clinical implications for efficacy and toxicity. The effect of neuroleptics and alpha-methyl-para-tyrosine on serum prolactin levels in laboratory animals and man.

  1978cited by this paper
• Prolactin responses to neuroleptics in normal and schizophrenic subjects.

  1978cited by this paper
• The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: neuroendocrine studies in normal men.

  1977cited by this paper
• Effect of sulpiride on serum prolactin levels in humans.

  1976cited by this paper
• A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

  1970cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Ziprasidone and the pharmacokinetics of a combined oral contraceptive.

  2000cites this paper
• Neuroendocrine responses to psychological workload of military flying

  1999cites this paper
• In vivo effects of remoxipride and aromatic ring metabolites in the rat.

  1997cites this paper
• Subhypnotic Doses of Propofol Do Not Possess Antidopaminergic Properties

  1997cites this paper
• In Vivo Effects of Remoxipride and Aromatic Ring Metabolites in the Rat 1

  1997cites this paper
• Biological predictors of antipsychotic treatment response

  1996cites this paper